DK3113764T3 - Farmaceutisk sammensætning til transmukosal afgivelse og fremgangsmåder til behandling af diabetes hos et individ, som har behov derfor - Google Patents
Farmaceutisk sammensætning til transmukosal afgivelse og fremgangsmåder til behandling af diabetes hos et individ, som har behov derfor Download PDFInfo
- Publication number
- DK3113764T3 DK3113764T3 DK15759080.3T DK15759080T DK3113764T3 DK 3113764 T3 DK3113764 T3 DK 3113764T3 DK 15759080 T DK15759080 T DK 15759080T DK 3113764 T3 DK3113764 T3 DK 3113764T3
- Authority
- DK
- Denmark
- Prior art keywords
- diabetes
- individual
- needs
- treatment
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461947698P | 2014-03-04 | 2014-03-04 | |
US201461947678P | 2014-03-04 | 2014-03-04 | |
PCT/IB2015/000390 WO2015132660A1 (en) | 2014-03-04 | 2015-03-04 | Pharmaceutical composition for transmucosal delivery and methods for treating diabetes in a subject in need thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3113764T3 true DK3113764T3 (da) | 2020-10-19 |
Family
ID=54016313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15759080.3T DK3113764T3 (da) | 2014-03-04 | 2015-03-04 | Farmaceutisk sammensætning til transmukosal afgivelse og fremgangsmåder til behandling af diabetes hos et individ, som har behov derfor |
Country Status (6)
Country | Link |
---|---|
US (1) | US10568936B2 (da) |
EP (1) | EP3113764B1 (da) |
CN (1) | CN106794146A (da) |
CA (1) | CA2978517A1 (da) |
DK (1) | DK3113764T3 (da) |
WO (1) | WO2015132660A1 (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106794146A (zh) | 2014-03-04 | 2017-05-31 | 伊斯特盖特医药公司 | 用于透粘膜递送的药物组合物以及用于在需要的受试者中治疗糖尿病的方法 |
GB201511284D0 (en) | 2015-06-26 | 2015-08-12 | Univ Witwatersrand Jhb | An oral pharmaceutical dosage form for the delivery of a peptide and/or protein |
CA3038882A1 (en) * | 2015-10-14 | 2017-06-08 | Pharcon Inc. | Composition for intraoral delivery of biologically active peptides and proteins |
CN107773545A (zh) * | 2016-08-29 | 2018-03-09 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物 |
JP2020508978A (ja) * | 2017-02-28 | 2020-03-26 | バイオリンガス アイピー エルエルシー | 舌下及びバッカル送達用のオイルベース製剤 |
WO2018191794A1 (en) | 2017-04-20 | 2018-10-25 | Zeenar Enterprises Pty Ltd | Liquid crystalline dosage form for administering a statin |
EP3664798A4 (en) | 2017-08-08 | 2021-05-05 | Kashiv Biosciences, LLC | PHARMACEUTICAL COMPOSITION WITH ELIGLUSTAT |
MA50414A (fr) | 2017-10-19 | 2020-08-26 | Mona E Buice | Composition à usage topique pour la cicatrisation améliorée des plaies ouvertes |
KR20200132852A (ko) * | 2018-01-23 | 2020-11-25 | 길라 테라퓨틱스, 인코포레이티드 | 펩티드 yy 약학적 제형, 조성물, 및 방법 |
CN112118831B (zh) * | 2018-05-17 | 2023-04-21 | 费尔廷制药公司 | 适用于活性药物成分的压片口香糖 |
WO2020082137A1 (en) * | 2018-10-25 | 2020-04-30 | Zeenar Enterprises Pty Ltd | Composition that forms liquid crystalline particles |
US20220169955A1 (en) * | 2019-02-04 | 2022-06-02 | Conopco Inc., D/B/A Unilever | Cleaning compositions |
WO2020174340A1 (en) * | 2019-02-25 | 2020-09-03 | Universidade Nova De Lisboa | Eutectic menthol-fatty acid combinations for wound healing |
JP2023525019A (ja) * | 2020-05-04 | 2023-06-14 | アンファスター・ファーマスーティカルズ・インコーポレイション | 薬剤の経鼻送達のための促進剤としての胆汁酸及びその塩の安全な使用 |
CN112294827B (zh) * | 2020-11-12 | 2021-12-24 | 四川大学华西医院 | 5-胆甾烯 -3β-醇硫酸酯盐的用途 |
CN113209052B (zh) * | 2021-03-16 | 2022-02-15 | 深圳市泰力生物医药有限公司 | 大麻二酚自纳米乳口颊膜制剂及其制备方法和用途 |
US20230058895A1 (en) * | 2021-08-06 | 2023-02-23 | Joseph Schwarz | Physiologically acceptable eutectic mixtures of cannabidiol |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5766620A (en) * | 1995-10-23 | 1998-06-16 | Theratech, Inc. | Buccal delivery of glucagon-like insulinotropic peptides |
WO2000047203A1 (en) | 1999-02-12 | 2000-08-17 | Mqs, Inc. | Formulation and system for intra-oral delivery of pharmaceutical agents |
US6432383B1 (en) * | 2000-03-30 | 2002-08-13 | Generex Pharmaceuticals Incorporated | Method for administering insulin |
US7138394B2 (en) * | 2002-09-27 | 2006-11-21 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
CN101005828B (zh) * | 2004-06-17 | 2012-01-11 | 维尔恩公司 | 用于经粘膜递送活性成分的包含粘膜粘附蛋白和所述活性物质的组合物 |
IL174387A0 (en) * | 2005-03-31 | 2008-01-20 | Dexcel Pharma Technologies Ltd | A solid composition for intra-oral delivery of insulin |
EP2243490B1 (en) * | 2007-12-28 | 2012-06-13 | Shanghai Institute of Pharmaceutical Industry | Insulin nasal powder inhalation |
WO2010118516A1 (en) * | 2009-04-14 | 2010-10-21 | Globe Laboratories Inc. | Compositions for sublingual drug delivery and methods of use thereof |
EP2958594A4 (en) * | 2013-02-22 | 2017-03-01 | Eastgate Pharmaceuticals Inc. | Pharmaceutical composition for enhanced transmucosal administration of benzodiazepines |
CN106794146A (zh) | 2014-03-04 | 2017-05-31 | 伊斯特盖特医药公司 | 用于透粘膜递送的药物组合物以及用于在需要的受试者中治疗糖尿病的方法 |
-
2015
- 2015-03-04 CN CN201580023729.3A patent/CN106794146A/zh active Pending
- 2015-03-04 CA CA2978517A patent/CA2978517A1/en not_active Abandoned
- 2015-03-04 EP EP15759080.3A patent/EP3113764B1/en active Active
- 2015-03-04 US US14/637,570 patent/US10568936B2/en not_active Expired - Fee Related
- 2015-03-04 WO PCT/IB2015/000390 patent/WO2015132660A1/en active Application Filing
- 2015-03-04 DK DK15759080.3T patent/DK3113764T3/da active
Also Published As
Publication number | Publication date |
---|---|
US20150250856A1 (en) | 2015-09-10 |
WO2015132660A1 (en) | 2015-09-11 |
US10568936B2 (en) | 2020-02-25 |
CN106794146A (zh) | 2017-05-31 |
EP3113764A1 (en) | 2017-01-11 |
EP3113764A4 (en) | 2017-08-30 |
EP3113764B1 (en) | 2020-07-22 |
CA2978517A1 (en) | 2015-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3113764T3 (da) | Farmaceutisk sammensætning til transmukosal afgivelse og fremgangsmåder til behandling af diabetes hos et individ, som har behov derfor | |
DK3368108T3 (da) | Medikamenttilførselsanordning | |
DK3722274T3 (da) | 2-perfluorbutylpentan til oftalmisk indgivelse | |
DK3265043T3 (da) | Hjælpemiddel til patienttransport og -træning | |
DK3139986T3 (da) | System til administration af terapeutisk gas | |
DK3145343T3 (da) | Aerosolfrembringende substrat og aerosolleveringssystem | |
DK3236943T3 (da) | Sammensætninger til ileo-jejunal lægemiddeladministration | |
DK3204876T3 (da) | Lægemiddelafgivelsesindretning | |
DK3337539T3 (da) | Medikamenttilførselsanordning til variable enkeltdoser | |
DK2986304T3 (da) | Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf. | |
DK3319611T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
DK3171921T3 (da) | Lægemiddelafgivelsesindretning | |
DK3319612T3 (da) | Oxysteroler og fremgansmåder til anvendelse derfor | |
DK3928763T3 (da) | Transmukosale og transdermale leveringssystemer | |
DK3094640T3 (da) | Fremgangsmåder til steril kromatografi og fremstilling | |
DK3233111T3 (da) | Farmaceutisk sammensætning, der omfatter plasminogen, og anvendelser deraf | |
EA201791454A1 (ru) | Лекарственные формы для трансдермального введения | |
DK3155017T3 (da) | Forbedrede lægemidler til insulinresistens | |
DK3554534T3 (da) | Farmaceutisk sammensætning omfattende insulin | |
DK3808188T1 (da) | Fiskefoder og fremgangsmåde til smoltifikation og forebyggelse af desmoltifikation hos salmonidae samt til profylakse og behandling af hæmoragisk smoltsyndrom (hss) hos salmonidae | |
DK3223796T3 (da) | Farmaceutiske sammensætninger, fremstilling og anvendelser deraf | |
DK3157522T3 (da) | Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste | |
DK3149049T3 (da) | Il-22 til anvendelse til behandling af stofskiftesygdomme | |
DK3353191T3 (da) | Cykliske polypeptider, fremgangsmåde til opnåelse deraf og terapeutisk anvendelse deraf |